![](https://endpts.com/wp-content/uploads/2020/09/Roy-Baynes-Merck-tile-scaled.jpg)
Roy Baynes, Merck
#WCLC21: Merck pokes Bristol Myers in the eye with Keytruda data showing safety red flags in Yervoy combo trial
In the rankings of big-name face-offs in pharma, few top the fight between Merck’s I/O rocket ship Keytruda and Bristol Myers Squibb’s Opdivo. Keytruda has …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.